Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 57,313 | 7,202 | 22,020 | N/A |
| Receivables | 558 | 184 | 49 | N/A |
| TOTAL | $59,552 | $8,824 | $22,162 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 118 | 149 | 14 | N/A |
| Other Non-Current Assets | 331 | 1,553 | 52 | 0 |
| TOTAL | $449 | $1,702 | $66 | $N/A |
| Total Assets | $60,001 | $10,526 | $22,228 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,599 | 603 | 5,822 | 0 |
| Accrued Expenses | 3,501 | 2,073 | 1,303 | N/A |
| TOTAL | $5,199 | $2,676 | $7,125 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 257 | 1,602 | 325 | 0 |
| TOTAL | $257 | $1,602 | $325 | $N/A |
| Total Liabilities | $5,456 | $4,278 | $7,450 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 17,835 | N/A | N/A | N/A |
| Common Shares | 18 | 4 | 4 | N/A |
| Retained earnings | -114,219 | -109,498 | -84,432 | N/A |
| Other shareholders' equity | 0 | 115,742 | 99,206 | 0 |
| TOTAL | $54,545 | $6,248 | $14,778 | $N/A |
| Total Liabilities And Equity | $60,001 | $10,526 | $22,228 | $0 |